Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Max Hodak"


7 mentions found


Elon Musk's brain-computer interface company, Neuralink, has implanted into a first human patient. AdvertisementElon Musk announced his brain interface company, Neuralink , implanted its first human brain chip last week. Courtesy of Blackrock NeurotechToday, most people who have a BCI implanted in their head have a Blackrock device. For now, all implanted BCIs are a way for people with severe forms of paralysis to regain independence, using their thoughts to control devices and access the internet. The neurodegenerative condition rendered key muscles in her face limp, but a BCI device is helping her communicate again.
Persons: Elon, Musk, who've, , Elon Musk, you'd, Blackrock Neurotech, Florian Solzbacher, Marcus Gerhardt, BrainGate Pat Bennett, Steve Fisch, Stanford Medicine BrainGate, Matthew Nagle, Nagle, they're, Gerhardt, Leigh Hochberg, Synchron, Dr, Thomas Oxley, Angela Weiss, stentrode, Musk —, Max Hodak, Hodak, didn't, Ann Johnson, Dutchman Gert, Jan Oksam, Oksam, we'll, Stephen Hawking Organizations: BCI, Service, Twitter, Blackrock, Blackrock Neurotech, Stanford Medicine, Brown University, BrainGate, Getty Images, Reuters, Bloomberg, University of California, Lausanne University, California –, Elon Locations: Massachusetts, Utah, Blackrock, Getty Images Brooklyn, Australia, San Francisco, Switzerland, California
Biotechnology startup and Neuralink competitor Science on Monday launched a new platform that aims to make it easier for other companies to quickly develop and produce medical devices. For many startups, that cost is too much to bear, but Hodak is hoping Science Foundry can help. The company's new platform Science Foundry aims to support companies working on similarly ambitious ideas. The cost of using Science Foundry is comparable to the cost of working with academic facilities, which are "cheap to get started," Hodak said. Hodak said the platform will benefit Science and the broader industry as a whole.
Companies that do secure human-testing approval typically conduct at least two rounds of trials before applying for FDA approval to commercially market a device. "Everybody in the industry was saying: 'Oh my God, they're going to run straight into a brick wall,'" Ludwig said of Musk's bid for FDA approval. For example, NeuroPace, which makes the brain implant to treat epilepsy, received final FDA approval in 2013 – 16 years after the company's launch. Beyond grants, it provides access to government experts who advise on how to gain FDA approval and commercialize a device. Musk's emails to Neuralink staffers often come from his SpaceX address, said two people who reviewed them.
Musk’s missed deadlines for FDA approval of Neuralink July 2019:Musk says Neuralink is aiming to receive regulatory approval for human trials of brain implants by the end of 2020. “Everybody in the industry was saying: ‘Oh my God, they’re going to run straight into a brick wall,’” Ludwig said of Musk’s bid for FDA approval. For example, NeuroPace, which makes the brain implant to treat epilepsy, received final FDA approval in 2013 – 16 years after the company’s launch. The FDA’s concerns about the battery are also potentially serious, experts in brain devices said. Still, that proposal disappointed Neuralink because it could delay progress toward final FDA approval, one of the sources said.
That's when I started reporting on them, and like any good nerd I was compelled by what scientists could learn with these "brain computer interfaces." The race for implantable brain chips has been a long, deliberate marathon. Graham Felstead, who has severe paralysis, was the first person to have a BCI inserted via the blood vessels. Brain chips will enable them to perform simple actions on their own and reduce the need for round-the-clock care. "When we started in 2015 and I was pitching venture capitalists on brain computer interfaces, no one knew what a brain computer interface was," says Matt Angle, the CEO of Paradromics.
In the early days of the industry, nonprofits and scrappy startups made up the psychedelics space. Research on compounds like psilocybin, the active compound found in magic mushrooms, and MDMA is resurfacing after years of neglect amid the war on drugs. Soon, VC firms focused on psychedelics companies began to emerge. Some psychedelics VCs, however, are still wary about entering the newest psychedelics space: Oregon's soon-to-be-legal magic mushroom market. Insider published a list of the psychedelics startups that raised the most cash in 2020.
Sursa foto: ShutterstockCofondatorul Neuralink vrea să creeze o lume Jurassic Park și specii noi de dinozauriMax Hodak, cofondatorul Neuralink, a anunțat că lucrează la construirea unei replici realiste după Jurassic Park. Pentru neinițiați, Jurassic Park și Jurassic World alcătuiesc o serie de cinci filme – cu un al șaselea în lucru – toate bazate pe romanul de succes al lui Michael Crichton. Romanul vorbește despre consecințele dezastruoase ale deschiderii unui loc ca Jurassic Park. Cu toate acestea, există o mare diferență între o idee bună și un experiment realizabil. Cu alte cuvinte, este o idee incitantă dar primejdioasă și dăunătoare – exact cum se întâmplă în filme.
Persons: Hodak, Michael Crichton, Max Hodak, . Organizations: Jurassic Park, Jurassic World
Total: 7